Disease/Infection News

RSS

HIV epidemic in MSM could be helped by better interaction with their health system

The second paper in The Lancet Series on HIV in MSM focuses on clinical care, and says that optimum clinical care for sexual and gender minorities is a fundamental human right. “MSM deserve to be treated with respect, and health-care providers need to interact with them in ways that promote disclosure of actionable health information,” say the authors, led by Dr Ken Mayer, Fenway Health, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

20 Jul 2012

HIV in MSM increasing in countries of all incomes

A new Lancet Series published to coincide with the AIDS2012 meeting highlights a population where the HIV epidemic is growing in countries of all incomes: men who have sex with men (MSM). The first paper in the Series charts the epidemiology of HIV among MSM, and is by Professor Chris Beyrer, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA, and colleagues.

20 Jul 2012

Scientists develop simple assay to diagnose 'superparasites'

Belgian scientists of the Institute of Tropical Medicine (ITM) in Antwerp, Belgium made a breakthrough in bridging high tech molecular biology research on microbial pathogens and the needs of the poorest of the poor. After sequencing the complete genome of Leishmania donovani (a parasite causing one of the most important tropical diseases after malaria) in hundreds of clinical isolates, they identified a series of mutations specific of 'superparasites' and developed a simple assay that should allow tracking them anywhere.

20 Jul 2012

Short-term infection with intestinal worms may provide long-term protection against TID

Short-term infection with intestinal worms may provide long-term protection against type I diabetes (TID), suggests a study conducted by William Gause, PhD, and colleagues at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School.

20 Jul 2012

ARV drug resistance levels steady in low-, middle-income countries, WHO report says

More widespread use of antiretroviral drugs (ARVs) to treat HIV infection has led to drug resistance in low- and middle-income countries, but the level "is not steep enough to cause alarm, said a survey released by the World Health Organization on Wednesday," Agence France-Presse reports.

20 Jul 2012

Blog highlights factors potentially affecting U.S. support for global AIDS response in 2013

In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Jenny Ottenhoff, policy outreach associate at the center, says "four big issues will impact U.S. support for the global response to the AIDS epidemic over the coming year."

20 Jul 2012

Community-based resources in rural Uganda can successfully provide HIV treatments

New research from the University of Alberta's School of Public Health has demonstrated that community-based resources in rural Uganda can successfully provide HIV treatments to patients, where economic and geographical barriers would typically prevent access to care.

20 Jul 2012

U.S. Secretary of State Clinton to address opening plenary session at AIDS 2012 conference

"U.S. Secretary of State Hillary Rodham Clinton will address the opening plenary session at the 19th International AIDS Conference (AIDS 2012), on Monday, July 23, 2012 at 10:00 a.m. at the Washington Convention Center, Session Room 1," a U.S. Department of State press notice reports.

20 Jul 2012

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

A funding analysis released on Wednesday by the Kaiser Family Foundation (KFF) and UNAIDS found that "funding to fight HIV/AIDS in low- and middle-income countries has remained flat at $7.6 billion," Politico Pro reports.

20 Jul 2012

CSIS official discusses upcoming AIDS 2012 conference, introduces new AIDS 2012 course on iTunes U

In this post in the Center for Strategic & International Studies' (CSIS) "Smart Global Health" blog, J. Stephen Morrison, senior vice president of CSIS and director of the CSIS Global Health Policy Center, reflects on the upcoming International AIDS Conference, which opens in Washington, D.C., on Sunday, writing, "It is a choice opportunity in the midst of our bitter electoral season to tell the good news of the extraordinary achievements, at home and abroad, in both science and delivery of effective treatment, care, and prevention to people living with HIV or at risk of infection."

20 Jul 2012

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

An international team of scientists, led by researchers from the Department of Pediatrics at the University of California, San Diego School of Medicine, have identified the first reported inhibitors of a key enzyme involved in survival of the parasite responsible for malaria. Their findings, which may provide the basis for anti-malarial drug development, are currently published in the online version of the Journal of Medicinal Chemistry.

20 Jul 2012

Scientists plan to announce research strategy aimed at pursuing HIV/AIDS cure, Wall Street Journal reports

On July 19, ahead of the XIX International AIDS Conference in Washington, D.C., "prominent AIDS scientists plan to announce the first comprehensive research strategy aimed at pursuing new leads and addressing hurdles to a cure" for HIV/AIDS, the Wall Street Journal reports.

20 Jul 2012

HealthHIV, CCO announce new series of CME/CE-certified interactive local live workshops

Clinical Care Options (CCO), a leader in next-generation medical education, information, and publishing for healthcare professionals, announces a new series of CME/CE-certified interactive local live workshops developed and implemented in partnership with HealthHIV, the leading national HIV nonprofit organization building the capacity of primary care providers to integrate HIV care into their practices.

20 Jul 2012

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to treat posterior uveitis with pSivida's injectable sustained-release micro-insert.

20 Jul 2012

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor.

20 Jul 2012

IMDx HSV-1/2 for Abbott m2000 assay receives CE-marking

IntelligentMDx (IMDx) announced today that it has obtained CE-marking for its fourth automated, high-throughput molecular test designed and developed for the Abbott m2000 System.

20 Jul 2012

PBS Newshour shares stories of those affected by HIV/AIDS epidemic

"As Washington prepares to host the International AIDS Conference from July 22-27, PBS NewsHour will profile some of the parallel stories unfolding around the epidemic on opposite ends of the globe," the news service writes. In the first of these stories, the news service profiles two individuals -- John Johnson in Washington, D.C., and Alice Sibanda in Hwange, Zimbabwe -- who as children lost their parents to the HIV/AIDS epidemic.

20 Jul 2012

Single-step method can rapidly detect pathogens and chemical contaminants

Using nanoscale materials, researchers at the University of Georgia have developed a single-step method to rapidly and accurately detect viruses, bacteria and chemical contaminants.

20 Jul 2012

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

We are at a moment of extraordinary optimism in the response to the human immunodeficiency virus (HIV). A series of scientific breakthroughs ... have the potential to markedly expand the available preventive tools. There is evidence of the first cure of an HIV-infected person. And most important, the finding that early initiation of antiretroviral therapy can both improve individual patient outcomes and reduce the risk of HIV transmission to sexual partners by 96% has led many to assert what had so long seemed impossible: that control of the HIV pandemic may be achievable.

20 Jul 2012

Primcogent Solutions introduces low level laser therapy for onychomycosis

Primcogent Solutions - supplier of the revolutionary ZERONA non-invasive body contouring technology in North America and Western Europe - has announced the launch of Lunula Laser, a clinically proven, low level laser therapy for onychomycosis, for distribution exclusively in Europe.

19 Jul 2012

Disease/Infection News

HIV epidemic in MSM could be helped by better interaction with their health system

HIV in MSM increasing in countries of all incomes

Scientists develop simple assay to diagnose 'superparasites'

Short-term infection with intestinal worms may provide long-term protection against TID

ARV drug resistance levels steady in low-, middle-income countries, WHO report says

Blog highlights factors potentially affecting U.S. support for global AIDS response in 2013

Community-based resources in rural Uganda can successfully provide HIV treatments

U.S. Secretary of State Clinton to address opening plenary session at AIDS 2012 conference

Donor nation funding for HIV remains at 2008 levels, Kaiser Family Foundation/UNAIDS analysis says

CSIS official discusses upcoming AIDS 2012 conference, introduces new AIDS 2012 course on iTunes U

Scientists identify inhibitors of key enzyme involved in survival of malaria parasite

Scientists plan to announce research strategy aimed at pursuing HIV/AIDS cure, Wall Street Journal reports

HealthHIV, CCO announce new series of CME/CE-certified interactive local live workshops

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

IMDx HSV-1/2 for Abbott m2000 assay receives CE-marking

PBS Newshour shares stories of those affected by HIV/AIDS epidemic

Single-step method can rapidly detect pathogens and chemical contaminants

Viewpoints: Researchers see potential to control HIV pandemic; The 'ceaseless attacks' on women's reproductive health

Primcogent Solutions introduces low level laser therapy for onychomycosis

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News